The Patent Trial and Appeal Board (PTAB) overstepped its jurisdiction when it determined that tribal sovereign immunity doesn't apply to inter partes review (IPR), according to the U.S. Court of Appeals for the Federal Circuit. Read More
Medicinova Inc.'s ibudilast, an experimental anti-inflammatory and neuroprotective agent that has undergone tests in a wide array of neurological conditions, has failed to help addicts kick methamphetamine (MA) dependence in a phase II study, despite early evidence suggesting that it might. Read More
HONG KONG – Japan's Carna Biosciences Inc. and Sumitomo Dainippon Pharma Co. Ltd. signed an agreement potentially worth about $100 million to work together on the research, development and commercialization of novel kinase inhibitors, focusing on psychiatric and neurological disorders. Read More
Esperite NV, of Amsterdam, said its biotechnology company, The Cell Factory, in collaboration with Women's and Children's Health Department of the University of Padua have developed the second generation of clinical-grade extracellular vesicles (EVs) enhanced with the protein annexin V (EV-AnV). Read More
The U.S. Government Accountability Office (GAO) found that the FDA followed its standard review process when it approved the application and revised labeling for Danco Laboratories LLC's Mifeprex (mifepristone), which is used for the medical termination of early pregnancy. Read More
